INSIGHTS ON QUALITY CONTROL

  • Modernizing Compendial SEC Methods For Biotherapeutics
    4/16/2024

    Explore the advantages of a bio-inert HPLC system through the migration and modernization of a compendial SEC method outlined in the United States Pharmacopeia (USP) General Chapter <129>.

  • A Comprehensive Solution For Critical Sample Analysis
    6/19/2024

    Discover how Germfree Laboratories overcame challenges for the Royal Canadian Mounted Police by designing a mobile lab with advanced biocontainment and state-of-the-art communication systems.

  • Consolidating The Supply Chain For mRNA
    2/12/2024

    Learn about the first end-to-end cGMP facility that was developed for mRNA manufacturing to address the shortage of CDMOs and the inadequate and inefficient supply chain options for sourcing GMP mRNA.

  • Utilizing A Stepwise Approach For Nitrosamine Risk Mitigation
    5/15/2025

    Insights and case studies demonstrate how a tailored, stepwise testing approach can effectively detect, quantify, and control nitrosamine impurities while maintaining cost efficiency.

  • CMO Validation As A Service
    8/20/2024

    Learn about the highly successful commissioning and qualification of Wheeler's Oklahoma City CDMO facility with the overarching goal of ensuring all equipment was qualified for a Phase 3 clinical production campaign.

QUALITY CONTROL SOLUTIONS

  • Understand how to confidently meet GxP compliance in the life sciences. Explore a framework encompassing people, processes, products, and services for regulatory adherence and data integrity.

  • In the pharmaceutical industry, microbiological monitoring and testing is highly regulated and complex. Discover how to optimize your QC lab's workflow and ensure compliance with proven services.

  • Tyvek® gives the premium microbial barrier protection for sterilized medical instruments and pharmaceuticals. Apart from protecting the medical devices and pharmaceutical products from physical damages, medical and pharmaceutical packages also should provide an effective microbial barrier and help to maintain the sterility of the products. Bacteria and viruses with sizes varying from 0.002 to 100 microns are a constant threat to pharmaceuticals and medical devices which in turn can be hazardous to the patients.

  • Upperton offers analytical services designed to support the development, monitoring, and quality control testing of pharmaceutical products.

  • Pyrogen detection is one of the mandatory release tests for sterile parenteral drugs testing in the course of pharmaceutical quality control. Test methods being used are the rabbit pyrogen test (RPT), the bacterial endotoxin test (or LAL test), and the monocyte activation test (MAT).